Compare KZR & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KZR | SCOR |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.7M | 32.8M |
| IPO Year | 2018 | 2007 |
| Metric | KZR | SCOR |
|---|---|---|
| Price | $6.25 | $7.08 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 35.4K | 16.5K |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $358,940,000.00 |
| Revenue This Year | N/A | $2.01 |
| Revenue Next Year | N/A | $1.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.77 |
| 52 Week Low | $3.53 | $4.39 |
| 52 Week High | $7.27 | $10.18 |
| Indicator | KZR | SCOR |
|---|---|---|
| Relative Strength Index (RSI) | 64.26 | 53.81 |
| Support Level | $6.05 | $6.40 |
| Resistance Level | $6.29 | $7.10 |
| Average True Range (ATR) | 0.14 | 0.43 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 76.00 | 84.85 |
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.